Lunesta DTC ads most recalled by TV viewers

Share this article:
DTC TV ads for Sepracor’s sleep aid Lunesta were the “most recalled” by consumers, according to new data from the advertising effectiveness rating firm IAG Research. Lunesta’s performance was also significant when compared to all other TV commercials, across all product categories, an IAG Research study conducted between September 2005 and September 2006 found. The “luna moth” that appears in the Lunesta spots, created by McCann-Erickson HumanCare, is recognized by adult viewers at a rate more than twice the average for all other new prescription drug ads, IAG Research said. Ads for Novartis’ irritable bowl syndrome treatment Zelnorm, from Deutsche and spots for Schering-Plough’s Nasonex, created by BBDO New York, also resonated with consumers, the study found. IAG Research’s pharmaceutical practice VP Fariba Zamaniyan said in a statement that “The above-average performances achieved by these brands confirm that direct-to-consumer advertising for prescription drugs can achieve breakthrough and brand recognition, even within the rigid guidelines this category faces.”
Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...